|
|
I J Goldberg, N A Le, H N Ginsberg, R M Krauss, F T Lindgren
J Clin Invest. 1988;
81(2):561
doi:10.1172/JCI113354
Abstract |
Full text
| PDF

T
o clarify the role of lipoprotein lipase (LPL) in the catabolism of nascent and circulating very low density lipoproteins (VLDL) and in the conversion of VLDL to low density lipoproteins (LDL), studies were performed in which LPL activity was inhibited in the cynomolgus monkey by intravenous infusion of inhibitory polyclonal or monoclonal antibodies. Inhibition of LPL activity resulted in a three- to fivefold increase in plasma triglyceride levels within 3 h. Analytical ultracentrifugation and gradient gel electrophoresis demonstrated an increase predominantly in more buoyant, larger VLDL (Sf 400-60). LDL and high density lipoprotein (HDL) cholesterol levels fell during this same time period, whereas triglyceride in LDL and HDL increased. Kinetic studies, utilizing radiolabeled human VLDL, demonstrated that LPL inhibition resulted in a marked decrease in the catabolism of large (Sf 400-100) VLDL apolipoprotein B (apoB). The catabolism of more dense VLDL (Sf 60-20) was also inhibited, although to a lesser extent. However, there was a complete block in the conversion of tracer in both Sf 400-100 and 60-20 VLDL apoB into LDL during LPL inhibition. Similarly, endogenous labeling of VLDL using [3H]leucine demonstrated that in the absence of LPL, no radiolabeled apoB appeared in LDL. We conclude that although catabolism of dense VLDL continues in the absence of LPL, this enzyme is required for the generation of LDL.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(13)
| Title and authors |
Publication |
Year |
Relative Atherogenicity and Predictive Value of Non–High-Density Lipoprotein Cholesterol for Coronary Heart Disease
Michael Miller, Henry N. Ginsberg, Ernst J. Schaefer
|
The American Journal of Cardiology
|
2008 |
Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene
Oscar Pérez-Méndez, Nathalie Duhal, Brigitte Lacroix, Jean-Paul Bonte, Jean-Charles Fruchart, Gérald Luc
|
Clinica Chimica Acta
|
2006 |
Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk
Jila Kaberi Otarod, Ira J. Goldberg
|
Curr Atheroscler Rep
|
2004 |
Genetic variation and statistical considerations in relation to overfeeding and underfeeding in humans
David H St-Pierre, Varghese George, Rémi Rabasa-Lhoret, Eric T Poehlman
|
Nutrition
|
2004 |
Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo
Weijun Jin, John S. Millar, Uli Broedl, Jane M. Glick, Daniel J. Rader
|
J. Clin. Invest.
|
2003 |
Pathogenesis and Management of Diabetic Dyslipidemia
Elena Izkhakov, Eyal Meltzer, Ardon Rubinstein
|
Treatments in Endocrinology
|
2003 |
Regulation of very low density lipoprotein apo B metabolism by dietary fat saturation and chain length in the guinea pig
Ghada Abdel-Fattah, Maria Luz Fernandez, Donald J. McNamara
|
Lipids
|
1998 |
In vitro production of β-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase
Byung Hong Chung, Jere P Segrest, Frank Franklin
|
Atherosclerosis
|
1998 |
Inhibition of lipoprotein lipase induced cholesterol ester accumulation in human hepatoma HepG2 cells
Katherine Cianflone, Rita Kohen Avramoglu, Cynthia Sawyez, Murray W. Huff
|
Atherosclerosis
|
1996 |
Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase
P.J.H. Pacy, K.A. Mitropoulos, S. Venkatesan, G.F. Watts, B.E.A. Reeves, D. Halliday
|
Atherosclerosis
|
1993 |
|